Pharmacology, Toxicology and Pharmaceutical Science
Nanocomposite
100%
Doxorubicin
72%
Silicon Dioxide
54%
Age Related Macular Degeneration
54%
Deoxyribonuclease I
54%
Verteporfin
54%
Mesoporous Silica
40%
Eye Drops
40%
Calcium Ion
32%
Bacterium
32%
Photothermal Therapy
32%
Neoplasm
31%
Drug
27%
Low Density Lipoprotein
27%
Nicotinic Acid
27%
Breast Cancer
27%
Chemotherapy
27%
Antiinfective Agent
24%
Combination Therapy
22%
Tumor Growth
22%
Gold Nanorod
22%
Mouse
22%
Photosensitizer
21%
Hyperthermia
19%
Methacrylate
18%
Adverse Drug Reaction
13%
Buffer
13%
Ligand
13%
Gelatin
13%
Drug Release
13%
6 Carboxyfluorescein
13%
Vasculotropin Inhibitor
13%
Intercellular Adhesion Molecule 1
13%
Low Density Lipoprotein Receptor
13%
Penetratin
13%
Lipoprotein A
13%
Eye Injury
13%
Subretinal Neovascularization
13%
Vasculotropin
13%
Neovascularization (Pathology)
13%
Peptide
13%
Lyase
10%
Glycerol
10%
Bacterial Clearance
10%
Calcium Phosphate
10%
Micelle
10%
DNA
10%
Polyethylene
10%
Glycerophosphoethanolamine
10%
Enzyme
10%
Medicine and Dentistry
Verteporfin
54%
Age Related Macular Degeneration
54%
Eye Drops
40%
Niacin
27%
Low-Density Lipoprotein
27%
Serositis
27%
6 Carboxyfluorescein
13%
Penetratin
13%
Local Therapy
13%
Vasculotropin
13%
Vasculotropin Inhibitor
13%
Blood-Retinal Barrier
13%
Choroidal Neovascularization
13%
Intercellular Adhesion Molecule 1
13%
LDL Receptor
13%
Eye Injury
13%
Lesion
13%
Aptitude
13%
Single Drug Dose
13%
Injection
13%
Combination Therapy
13%
Nanoparticle
13%
Peptide
13%
Chemistry
Nanocomposite
32%
Polymer
32%
Acidic Condition
10%
Glycerol
10%
Antimicrobial Agent
10%
Sn-Glycero-3-Phosphoethanolamine
10%
Calcium Phosphate
10%
Procedure
10%
Surface
10%
Hydrophobic Surface
10%
Environment
10%
Structure
10%
Deoxyribonucleic Acid
10%
